Skip to main content

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials.

Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research.

Debates will also be encouraged in the correspondence section of this journal.

Publisher: Bentham Science Publishers

Volume 5, Number 3, July 2007

Articles

Editorial [PCI and Stable Coronary Heart Disease - COURAGE to Change Our Minds?]
pp. 173-174(2)
Authors: Anna I. Kakafika; Dimitri P. Mikhailidis; Anthony S. Wierzbicki; Asterios Karagiannis; Vasilios G. Athyros

Favourites:
ADD

Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
pp. 175-184(10)
Authors: John C. Ashton; Paul F. Smith

Favourites:
ADD

Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management
pp. 185-194(10)
Authors: Joachim R. Ehrlich; Stanley Nattel; Stefan H. Hohnloser

Favourites:
ADD

Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease
pp. 195-209(15)
Authors: Dimitrios Mikroulis; Nikolaos Papanas; Efstratios Maltezos; Georgios Bougioukas

Favourites:
ADD

New Pharmacologic Approaches to Prevent Thromboembolism in Patients with Atrial Fibrillation
pp. 211-219(9)
Authors: Matthias Hammwohner; Alessandra D'Alessandro; Oliver Wolfram; Andreas Goette

Favourites:
ADD

Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
pp. 227-237(11)
Authors: Polychronis Dilaveris; Georgios Giannopoulos; Maria Riga; Andreas Synetos; Christodoulos Stefanadis

Favourites:
ADD

The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies
pp. 239-248(10)
Authors: Martin Smollich; Pia Wulfing

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more